Top

Supportive Care in Cancer

Published in:

01-11-2017 | Letter to the editor

Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology

Authors: Christopher C Blyth, Gabrielle M Haeusler, Brendan J McMullan, Rishi S Kotecha, Monica A Slavin, Julia E Clark

Published in: Supportive Care in Cancer | Issue 11/2017

Excerpt

Dear Editor, …

Morgan JE et al (2017) Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology. Support Care Cancer 25(1):221–228CrossRef

Brouwers MC et al (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ 182(18):E839–E842CrossRef

Blyth, C.C., T.A. O'Brien, and P. Palasanthiran (2007) Australasian guideline for antifungal therapy in neonates and children with proven, probable and suspected fungal infecti0ons. : http://www.mycology.adelaide.edu.au/virtual/guidelines/

Blyth CC et al (2014) Consensus guidelines for the treatment of invasive mould infections in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 44(12b):1333–1349CrossRef

Chang CC et al (2014) Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014. Intern Med J 44(12b):1389–1397CrossRef

Chau MM et al (2014) Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Intern Med J 44(12b):1364–1388CrossRef

Chen SC et al (2014) Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014. Intern Med J 44(12b):1315–1332CrossRef

Cooley L et al (2014) Consensus guidelines for diagnosis, prophylaxis and management of pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Intern Med J 44(12b):1350–1363CrossRef

Fleming S et al (2014) Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 44(12b):1283–1297CrossRef

10.

Morrissey CO et al (2014) Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J 44(12b):1298–1314CrossRef

11.

Slavin MA et al (2014) Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014. Intern Med J 44(12b):1267–1276CrossRef

12.

van Hal SJ et al (2014) Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand. Intern Med J 44(12b):1277–1282CrossRef

Title: Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology
Authors: Christopher C Blyth
Gabrielle M Haeusler
Brendan J McMullan
Rishi S Kotecha
Monica A Slavin
Julia E Clark
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 11/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3681-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2017

Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study

Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations

Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy

Designing more engaging computer-tailored physical activity behaviour change interventions for breast cancer survivors: lessons from the iMove More for Life study

Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

A qualitative evaluation of breast cancer survivors’ acceptance of and preferences for consumer wearable technology activity trackers

Keynote webinar | Spotlight on antibody–drug conjugates in cancer